It is now over two years since OAM began. Yet to date, no evaluation of an alternative treatment has been completed. Evaluations of antineoplastons, shark cartilage, the Revici method, and bee pollen are moving so slowly that it often appears nothing is happening. This is troubling. Congress set up this office to investigate and validate alternative treatments for cancer and other major diseases.
Delays are very demoralizing to staff and advisors alike.
The alternative-using public is growing weary of what it sees as bureaucratic delays. The people want to know the truth about various alternative treatments. OCAM list Ralph W. Moss, Ph.D. is director of the The Moss Reports for cancer patients. Dr. Moss is the author of eleven books and three documentaries on cancer-related topics. He is or has been an advisor on alternative cancer treatments to the National Institutes of Health, the National Cancer Institute, the American Urological Association, Columbia University, the University of Texas, the Susan G. Komen Foundation and the German Society of Oncology.